| CPC A61K 31/196 (2013.01) [A61K 31/18 (2013.01); A61K 31/195 (2013.01); A61K 31/63 (2013.01); A61P 25/28 (2018.01)] | 10 Claims |

|
1. A composition for treatment of an illness related to amyloid aggregation, wherein the composition comprises an effective amount of a fluorinated benzensulfonamide compound as part of a pharmaceutical formulation, wherein the fluorinated benzensulfonamide compound is of structure I or a pharmaceutically acceptable salt thereof:
![]() wherein X is S, NH or SO2;
NHR2 and F are at ortho and meta positions with respect to the sulfonamide group, such that
when X═S or NH, NHR2 is at ortho position and F is at meta position, and when X═SO2,
NHR2 is at meta position and F is at ortho position;
R1 is selected from the group consisting of:
![]() wherein n=0, 1, or 2, and COOH is at the position ortho, meta, or para, as shown:
![]() benzene-dicarboxylic acid, wherein n=0, 1, or 2, and COOH groups are at different positions of benzene ring, as shown:
![]() and
2-phenylacetic acid, as shown:
![]() R2 is cycloalkyl wherein cycloalkyl comprises cycloalkanes from cyclooctane to cyclotetradecane (C8-C14),
cycloalkylmethyl wherein cycloalkyl comprises cycloalkanes from cyclohexane to cyclododecane (C6-C12),
alkyl where alkyl comprises alkanes from hexane to tetradecane (C6-C14), or
alkyl where alkyl comprises branched alkanes from C6 to C14.
|